JAMA
Editorial
April 2, 2019
Clifford R. Jack Jr, MD; Ronald C. Petersen, MD, PhD
JAMA. 2019; 321(13):1258-1260. doi: 10.1001/jama.2019.1998
JAMA
Research Letter
April 2, 2019
Alexander L. Fogel, MD, MBA; Joseph C. Kvedar, MD
JAMA. 2019; 321(13):1309-1310. doi: 10.1001/jama.2019.0395
In response to physicians’ concerns about exposure to malpractice risk in direct-to-consumer (DTC) telemedicine, this study reviews the LexisNexis legal case database for reported cases of medical malpractice related to DTC telemedicine services or their health care professionals.
JAMA
Comment & Response
April 2, 2019
Ivan de Kouchkovsky, MD; Jacob Mayfield, MD; Jeffrey Kohlwes, MD, MPH
JAMA. 2019; 321(13):1310-1310. doi: 10.1001/jama.2019.0061
JAMA
Comment & Response
April 2, 2019
Cornelis Slagt, MD, PhD; Lucas van Eijk, MD, PhD
JAMA. 2019; 321(13):1311-1312. doi: 10.1001/jama.2019.0298
JAMA
Comment & Response
April 2, 2019
Madeline McCrary, MD; Jennifer Goldstein, MD, MSc
JAMA. 2019; 321(13):1313-1314. doi: 10.1001/jama.2019.0302
JAMA
Comment & Response
April 2, 2019
Yuichiro Yano, MD, PhD; Paul Muntner, PhD; Donald Lloyd-Jones, MD, ScM
JAMA. 2019; 321(13):1310-1311. doi: 10.1001/jama.2019.0065
JAMA
Comment & Response
April 2, 2019
Ary Serpa Neto, MD, MSc, PhD; Fabienne D. Simonis, MD; Marcus J. Schultz, MD, PhD
JAMA. 2019; 321(13):1312-1313. doi: 10.1001/jama.2019.0306
JAMA
Comment & Response
April 2, 2019
Cara Tannenbaum, MD, MSc; Robyn Tamblyn, PhD
JAMA. 2019; 321(13):1314-1314. doi: 10.1001/jama.2019.0311
JAMA
Original Investigation
April 2, 2019
Gil D. Rabinovici, MD; Constantine Gatsonis, PhD; Charles Apgar, MBA; Kiran Chaudhary, MS; Ilana Gareen, PhD; Lucy Hanna, MS; James Hendrix, PhD; Bruce E. Hillner, MD; Cynthia Olson, MBA; Orit H. Lesman-Segev, MD; Justin Romanoff, MA; Barry A. Siegel, MD; Rachel A. Whitmer, PhD; Maria C. Carrillo, PhD
is active quiz
JAMA. 2019; 321(13):1286-1294. doi: 10.1001/jama.2019.2000
In an attempt to understand if amyloid PET imaging improves the care of patients with MCI or dementia, this cohort study investigates associations between information provided by amyloid PET scan and change in clinical management, defined as a composite of change in drug therapy or counseling about safety and future planning.
JAMA
JAMA Patient Page
April 2, 2019
Cristen Olds, MD; Sam P. Most, MD
free access
JAMA. 2019; 321(13):1320-1320. doi: 10.1001/jama.2019.1957
This JAMA Patient Page describes the upper blepharoplasty procedure.
JAMA
Review
April 2, 2019
Bradley A. Gross, MD; Brian T. Jankowitz, MD; Robert M. Friedlander, MD
is active quiz
JAMA. 2019; 321(13):1295-1303. doi: 10.1001/jama.2019.2413
This narrative review summarizes the pathophysiology, presentation, and management of patients with intraparenchymal hemorrhagic stroke, and approaches to poststroke rehabilitation, risk factor management, and anticoagulation.
JAMA
The JAMA Forum
April 2, 2019
Pranammya Dey, BS; Peter B. Bach, MD
free access
JAMA. 2019; 321(13):1242-1243. doi: 10.1001/jama.2019.2320